Cited by 1,317Cancer Genomics and DiagnosticsPancreatic and Hepatic Oncology ResearchChromatin Remodeling and Cancer

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Open access

Campbell, Peter J., Yachida, Shinichi, Mudie, Laura J., Stephens, Philip J., Pleasance, Erin D., Stebbings, Lucy A., Morsberger, Laura A., Latimer, Calli, McLaren, Stuart, Lin, Meng-Lay, McBride, David J., Varela, Ignacio, Nik-Zainal, Serena A., Leroy, Catherine, Jia, Mingming, Menzies, Andrew, Butler, Adam P., Teague, Jon W., Griffin, Constance A., Burton, John, Swerdlow, Harold, Quail, Michael A., Stratton, Michael R., Iacobuzio-Donahue, Christine, Futreal, P. Andrew·2010·Nature

DOI 10.1038/nature09460PMC PMC3137369

Open this paper in CoChat — free account

Abstract

Pancreatic cancer is an aggressive malignancy with a five-year mortality of 97-98%, usually due to widespread metastatic disease. Previous studies indicate that this disease has a complex genomic landscape, with frequent copy number changes and point mutations, but genomic rearrangements have not been characterized in detail. Despite the clinical importance of metastasis, there remain fundamental questions about the clonal structures of metastatic tumours, including phylogenetic relationships among metastases, the scale of ongoing parallel evolution in metastatic and primary sites, and how the tumour disseminates. Here we harness advances in DNA sequencing to annotate genomic rearrangements in 13 patients with pancreatic cancer and explore clonal relationships among metastases. We find that pancreatic cancer acquires rearrangements indicative of telomere dysfunction and abnormal cell-cycle control, namely dysregulated G1-to-S-phase transition with intact G2-M checkpoint. These initiate amplification of cancer genes and occur predominantly in early cancer development rather than the later stages of the disease. Genomic instability frequently persists after cancer dissemination, resulting in ongoing, parallel and even convergent evolution among different metastases. We find evidence that there is genetic heterogeneity among metastasis-initiating cells, that seeding metastasis may require driver mutations beyond those required for primary tumours, and that phylogenetic trees across metastases show organ-specific branches. These data attest to the richness of genetic variation in cancer, brought about by the tandem forces of genomic instability and evolutionary selection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature09460

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citation
Mapping short DNA sequencing reads and calling variants using mapping quality scores
Li, H., Ruan, J., & Durbin, R. (2008) · Genome Research · doi:10.1101/gr.078212.108 · Cited by 2,638
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
A comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696
Self-citation
THE STABILITY OF BROKEN ENDS OF CHROMOSOMES IN ZEA MAYS
McClintock, B. (1941) · Genetics · doi:10.1093/genetics/26.2.234 · Cited by 1,605
Pancreatic cancer biology and genetics
Bardeesy, N. M., & DePinho, R. A. (2002) · Nature reviews. Cancer · doi:10.1038/nrc949 · Cited by 1,175
Parallel progression of primary tumours and metastases
Klein, C. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2627 · Cited by 1,161
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,144
A small-cell lung cancer genome with complex signatures of tobacco exposure
Pleasance, E., Stephens, P. J., O’Meara, S., McBride, D. J., Meynert, A. M., Jones, D., Lin, M., Beare, D. M., Lau, K. W., Greenman, C., et al. (2009) · Nature · doi:10.1038/nature08629 · Cited by 1,076
Self-citation
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J. S., Prentice, L., Pugh, T. J., Burleigh, A., Delaney, A. D., Gelmon, K. A., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,063

Flagged first, then by citations

Show all 30 references

Sorted by citations

Items 601–700 of 1,000

Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib
Fraunhoffer, N. A., Abuelafia, A. M., Bigonnet, M., Gayet, O., Roques, J., Telle, E., Santofimia‐Castaño, P., Borrello, M. T., Chuluyán, E., Dusetti, N., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1232 · Cited by 35
Silencing of Long Non-Coding RNA HOTAIR Alleviates Epithelial–Mesenchymal Transition in Pancreatic Cancer via the Wnt/β-Catenin Signaling Pathway
Tang, Y., Song, G. Y., Liu, H., Yang, S., Yu, X., & Shi, L. (2021) · Cancer Management and Research · doi:10.2147/cmar.s265578 · Cited by 35
An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability
Hayford, C. E., Tyson, D. R., Robbins, C. T., Frick, P. L., Quaranta, V., & Harris, L. A. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3000797 · Cited by 38
Pancreatic cancer stem cells: new insights and perspectives
Dorado, J., Lonardo, E., Miranda‐Lorenzo, I., & Heeschen, C. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0422-x · Cited by 35
Telomeres and Cancer: From Crisis to Stability to Crisis to Stability
Campbell, P. J. (2012) · Cell · doi:10.1016/j.cell.2012.01.043 · Cited by 36
Self-citation
Genomic sequencing in cancer
Tuna, M., & Amos, C. I. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.004 · Cited by 37
Molecular Mechanism Underlying Lymphatic Metastasis in Pancreatic Cancer
Xiao, Z., Luo, G., Liu, C., Wu, C., Liu, L., Liu, Z., Ni, Q., Long, J., & Yu, X. (2014) · BioMed Research International · doi:10.1155/2014/925845 · Cited by 35
Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer
Aravindan, S., Ramraj, S. K., Somasundaram, S. T., Herman, T. S., & Aravindan, N. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0173-3 · Cited by 34
DNA replication: Failures and inverted fusions
Carr, A. M., Paek, A. L., & Weinert, T. A. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.10.008 · Cited by 39
Pilot Phase I/II Personalized Therapy Trial for Metastatic Colorectal Cancer: Evaluating the Feasibility of Protein Pathway Activation Mapping for Stratifying Patients to Therapy with Imatinib and Panitumumab
Pierobon, M., Silvestri, A., Spira, A. I., Reeder, A., Pin, E., Banks, S., Parasido, E., Edmiston, K. H., Liotta, L. A., & Petricoin, E. F. (2014) · Journal of Proteome Research · doi:10.1021/pr401267m · Cited by 34
Translating Genomics to the Clinic: Implications of Cancer Heterogeneity
Samuel, N., & Hudson, T. J. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.184580 · Cited by 34
New and emerging factors in tumorigenesis: an overview
Kim, S. (2015) · Cancer Management and Research · doi:10.2147/cmar.s47797 · Cited by 34
State of the art biological therapies in pancreatic cancer
Marco, M. D. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i1.55 · Cited by 34
Cancer heterogeneity: converting a limitation into a source of biologic information
Rübben, A., & Araujo, A. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1290-9 · Cited by 36
Role of nitric oxide in pancreatic cancer cells exhibiting the invasive phenotype
Fujita, M., Somasundaram, V., Basudhar, D., Cheng, R. Y. S., Ridnour, L. A., Higuchi, H., Imadome, K., No, J. H., Bharadwaj, G., & Wink, D. A. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101158 · Cited by 34
NOP14 promotes proliferation and metastasis of pancreatic cancer cells
Zhou, B., Wu, Q., Chen, G., Zhang, T., & Zhao, Y.-P. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.010 · Cited by 34
A new branch on the tree: Next-generation sequencing in the study of cancer evolution
Brosnan‐Cashman, J. A., & Iacobuzio–Donahue, C. A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.12.008 · Cited by 35
Self-citation
Opening Pandora's Box — the new biology of driver mutations and clonal evolution in cancer as revealed by next generation sequencing
Ma, Q. C., Ennis, C. A., & Aparicio, S. A. J. R. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.01.008 · Cited by 35
PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer
Liu, Q., Guo, L. T., Zhang, S., Wang, J., Lin, X., & Gao, F. (2019) · Molecular Medicine · doi:10.1186/s10020-019-0111-4 · Cited by 33
Genomic heterogeneity in pancreatic cancer organoids and its stability with culture
Usman, O. H., Zhang, L., Xie, G., Kocher, H. M., Hwang, C., Wang, Y. J., Mallory, X., & Irianto, J. (2022) · npj Genomic Medicine · doi:10.1038/s41525-022-00342-9 · Cited by 36
GROM-RD: resolving genomic biases to improve read depth detection of copy number variants
Smith, S. D., Kawash, J., & Grigoriev, A. (2015) · PeerJ · doi:10.7717/peerj.836 · Cited by 34
Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation
Viergever, B. J., Raats, D., Geurts, V., Mullenders, J., Jonges, T. G. N., van der Heijden, M. S., van Es, J. H., Kranenburg, O., & Meijer, R. P. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02494-6 · Cited by 32
Genomic evolution of metastasis
Luebeck, E. G. (2010) · Nature · doi:10.1038/4671053a · Cited by 32
Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens
Brastianos, P. K., Nayyar, N., Rosebrock, D., Leshchiner, I., Gill, C. M., Livitz, D. G., Bertalan, M. S., D’Andrea, M. R., Hoang, K., Aquilanti, E., et al. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0035-9 · Cited by 32
Liquid Biopsy Based Single‐Cell Transcriptome Profiling Characterizes Heterogeneity of Disseminated Tumor Cells from Lung Adenocarcinoma
Dong, Y., Wang, Z., & Shi, Q. (2020) · PROTEOMICS · doi:10.1002/pmic.201900224 · Cited by 32
Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic
Du, Y., Zhao, B., Liu, Z., Ren, X., Zhao, W., Li, Z., You, L., & Zhao, Y. (2017) · Journal of Cancer · doi:10.7150/jca.17622 · Cited by 32
The Potent G-Quadruplex-Binding Compound QN-302 Downregulates S100P Gene Expression in Cells and in an In Vivo Model of Pancreatic Cancer
Ahmed, A., Greenhalf, W., Palmer, D., Williams, N., Worthington, J., Arshad, T., Haider, S., Alexandrou, E., Guneri, D., Waller, Z., et al. (2023) · Molecules · doi:10.3390/molecules28062452 · Cited by 22
Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities
Min, K. K. M., Ffrench, C. B., Jessup, C. F., Shepherdson, M., Barreto, S. G., & Bonder, C. S. (2023) · Cancers · doi:10.3390/cancers15082354 · Cited by 35
Detection of chromothripsis‐like patterns with a custom array platform for chronic lymphocytic leukemia
Salaverría, I., Martin‐García, D., López, C., Clot, G., García‐Aragonés, M., Navarro, A., Delgado, J., Baumann, T., Pinyol, M., Martín‐Guerrero, I., et al. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22277 · Cited by 31
Detailed imaging and genetic analysis reveal a secondary BRAFL 505H resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib
Hoogstraat, M., Hooijdonk, C. G. G., Ubink, I., Besselink, N. J. M., Pieterse, M., Veldhuis, W. B., van Stralen, M., Meijer, E. F. J., Willems, S. M., Hadders, M. A., et al. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12347 · Cited by 31
Requirements for Vitamin D Across the Life Span
Grant, W. B., & Boucher, B. J. (2011) · Biological Research For Nursing · doi:10.1177/1099800410391243 · Cited by 31
High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution
Carlotti, E., Wrench, D., Rosignoli, G., Marzec, J., Sangaralingam, A., Hazanov, L., Michaeli, M., Hallam, S. L., Chaplin, T., Iqbal, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134833 · Cited by 32
Self-citation
Deciphering Genetic Intratumor Heterogeneity and Its Impact on Cancer Evolution
Rosenthal, R., McGranahan, N., Herrero, J., & Swanton, C. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-042516-011348 · Cited by 33
Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases
Nicosia, L., Cuccia, F., Mazzola, R., Figlia, V., Giaj‐Levra, N., Ricchetti, F., Rigo, M., Bonù, M. L., Corradini, S., Tolia, M., et al. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03223-9 · Cited by 31
Molecular Profiles of Brain Metastases: A Focus on Heterogeneity
Ali, S., Górska, Z., Duchnowska, R., & Jassem, J. (2021) · Cancers · doi:10.3390/cancers13112645 · Cited by 33
FAM190A Deficiency Creates a Cell Division Defect
Patel, K. G., Scrimieri, F., Ghosh, S., Zhong, J., Kim, M., Ren, Y. R., Morgan, R. A., Iacobuzio–Donahue, C. A., Pandey, A., & Kern, S. E. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.03.020 · Cited by 31
Self-citation
Studies in rodents with the dipeptidyl peptidase‐4 inhibitor vildagliptin to evaluate possible drug‐induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man
Busch, S. J., Hoffmann, P., Sahota, P. S., Johnson, R., Kothny, W., Meyer, F., & Foley, J. E. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01678.x · Cited by 29
Cell-Free Plasma MicroRNA in Pancreatic Ductal Adenocarcinoma and Disease Controls
Carlsen, A. L., Jøergensen, M. T., Knudsen, S., de Muckadell, O. B. S., & Heegaard, N. H. H. (2013) · Pancreas · doi:10.1097/mpa.0b013e318296bb34 · Cited by 30
Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors
Albitar, A., Ma, W., DeDios, I., Estella, J. J., Ahn, I. E., Farooqui, M. Z. H., Wiestner, A. U., & Albitar, M. X. (2017) · Oncotarget · doi:10.18632/oncotarget.15316 · Cited by 30
miR-144-3p Targets FosB Proto-oncogene, AP-1 Transcription Factor Subunit (FOSB) to Suppress Proliferation, Migration, and Invasion of PANC-1 Pancreatic Cancer Cells
Liu, S., Luan, J., & Ding, Y. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x14982585511252 · Cited by 30
Retracted
Multi-omic molecular comparison of primary versus metastatic pancreatic tumours
Brar, G. S., Blais, E. M., Bender, R. J., Brody, J. R., Sohal, D. P. S., Madhavan, S., Picozzi, V. J., Hendifar, A. E., Chung, V. M., Halverson, D., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0507-5 · Cited by 30
XGBoost Classifier Based on Computed Tomography Radiomics for Prediction of Tumor-Infiltrating CD8+ T-Cells in Patients With Pancreatic Ductal Adenocarcinoma
Li, J., Shi, Z., Liu, F., Fang, X., Cao, K., Meng, Y., Zhang, H., Yu, J., Feng, X., Li, Q., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.671333 · Cited by 29
A role for AKT1 in nonsense-mediated mRNA decay
Palma, M., Leroy, C., Salomé‐Desnoulez, S., Werkmeister, E., Kong, R., Mongy, M., Hir, H. L., & Lejeune, F. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab882 · Cited by 29
Self-citation
Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression
Mota, A., Oltra, S. S., Selenica, P., Moiola, C. P., Casas‐Arozamena, C., López-Gil, C., Díaz, E., Gatius, S., Ruiz-Miró, M., Calvo, A., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02221-0 · Cited by 30
Human Correlates of Provocative Questions in Pancreatic Pathology
McDonald, O. G., Maitra, A., & Hruban, R. H. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e318273f998 · Cited by 30
Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway
Chen, Y., Huang, R., Ding, J., Ji, D., Song, B., Yuan, L., Chang, H., & Chen, G. (2015) · Scientific Reports · doi:10.1038/srep09925 · Cited by 30
JAK2 and genomic instability in the myeloproliferative neoplasms: A case of the chicken or the egg?
Scott, L. M., & Rebel, V. I. (2012) · American Journal of Hematology · doi:10.1002/ajh.23243 · Cited by 31
Physics of Cancer: The Impact of Heterogeneity
Zhang, Q., & Austin, R. H. (2011) · Annual Review of Condensed Matter Physics · doi:10.1146/annurev-conmatphys-020911-125109 · Cited by 30
Prognostic value of combining a quantitative image feature from positron emission tomography with clinical factors in oligometastatic non-small cell lung cancer
Jensen, G. L., Yost, C. M., Mackin, D., Fried, D., Zhou, S., Court, L. E., & Gomez, D. R. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.11.006 · Cited by 30
Bone serves as a transfer station for secondary dissemination of breast cancer
Huang, Y., Wang, H., Yue, X., & Li, X. (2023) · Bone Research · doi:10.1038/s41413-023-00260-1 · Cited by 33
Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia
Lang, F., Wojcik, B., & Rieger, M. A. (2015) · Stem Cells International · doi:10.1155/2015/137164 · Cited by 29
The evolving cancer stem cell paradigm: Implications in veterinary oncology
Pang, L. Y., & Argyle, D. J. (2015) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.12.029 · Cited by 29
New approach to cancer therapy based on a molecularly defined cancer classification
Cortés, J., Calvo, E., Vivancos, A. P., Pérez-García, J. M., Recio, J. A., & Seoane, J. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21211 · Cited by 31
Intratumor genetic heterogeneity in squamous cell carcinoma of the oral cavity
Zandberg, D. P., Tallon, L. J., Nagaraj, S., Sadzewicz, L., Zhang, Y., Strome, M. B., Zhao, X., Vavikolanu, K., Zhang, X., Papadimitriou, J. C., et al. (2019) · Head & Neck · doi:10.1002/hed.25719 · Cited by 30
Immune cell infiltrates as prognostic biomarkers in pancreatic ductal adenocarcinoma: a systematic review and meta‐analysis
McGuigan, A. J., Coleman, H. G., McCain, R. S., Kelly, P. J., Johnston, D. I., Taylor, M., & Turkington, R. C. (2021) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.192 · Cited by 33
N-cadherin functions as a growth suppressor in a model of K-ras-induced PanIN
Su, Y., Li, J., Shi, C., Hruban, R. H., & Radice, G. L. (2015) · Oncogene · doi:10.1038/onc.2015.382 · Cited by 32
Coiled-coil domain containing 68 (CCDC68) demonstrates a tumor-suppressive role in pancreatic ductal adenocarcinoma
Radulovich, N., Leung, L., Ibrahimov, E., Navab, R., Sakashita, S., Zhu, C.-Q., Kaufman, E. L., Lockwood, W. W., Thu, K. L., Fedyshyn, Y., et al. (2014) · Oncogene · doi:10.1038/onc.2014.357 · Cited by 29
Pre-analytics and tumor heterogeneity
Bonin, S., & Stanta, G. (2019) · New Biotechnology · doi:10.1016/j.nbt.2019.09.007 · Cited by 29
Cancer genome sequencing: Understanding malignancy as a disease of the genome, its conformation, and its evolution
Patel, L. R., Nykter, M., Chen, K., & Zhang, W. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.018 · Cited by 28
KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma
Paliogiannis, P., Cossu, A., Tanda, F., Palmieri, G., & Palomba, G. (2014) · Oncology Letters · doi:10.3892/ol.2014.2411 · Cited by 27
Pancreatic cancer stem cell biology and its therapeutic implications
Bednar, F., & Simeone, D. M. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-011-0494-7 · Cited by 27
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma
Evers, L., Pérez-Mancera, P. A., Lenkiewicz, E., Tang, N., Aust, D., Knösel, T., Rümmele, P., Holley, T., Kassner, M., Aziz, M., et al. (2014) · Genome Medicine · doi:10.1186/gm526 · Cited by 28
A Decrease in miR-150 Regulates the Malignancy of Pancreatic Cancer by Targeting c-Myb and MUC4
Yang, K., He, M., Cai, Z., Ni, C.-R., Deng, J., Ta, N., Xu, J., & Zheng, J. (2015) · Pancreas · doi:10.1097/mpa.0000000000000283 · Cited by 28
Deciphering intratumor heterogeneity using cancer genome analysis
Ryu, D., Joung, J., Kim, N. K. D., Kim, K., & Park, W. (2016) · Human Genetics · doi:10.1007/s00439-016-1670-x · Cited by 28
How Subclonal Modeling Is Changing the Metastatic Paradigm
Macintyre, G., Loo, P. V., Corcoran, N. M., Wedge, D. C., Markowetz, F. M., & Hovens, C. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0234 · Cited by 28
Signatures of positive selection reveal a universal role of chromatin modifiers as cancer driver genes
Zapata, L., Sušak, H., Drechsel, O., Friedländer, M. R., Estivill, X., & Ossowski, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12888-1 · Cited by 29
An engineered pancreatic cancer model with intra-tumoral heterogeneity of driver mutations
Moon, H., Özçelikkale, A., Yang, Y., Elzey, B. D., Konieczny, S. F., & Han, B. (2020) · Lab on a Chip · doi:10.1039/d0lc00707b · Cited by 27
MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer
Zhao, S., Hou, D., Zheng, X., Song, W., Liu, X., Wang, S., Zhou, L., Tao, X., Lv, L., Sun, Q., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-361 · Cited by 26
MesKit: a tool kit for dissecting cancer evolution of multi-region tumor biopsies through somatic alterations
Liu, M., Chen, J., Wang, X., Wang, C., Zhang, X., Xie, Y., Zuo, Z., Ren, J. M., & Zhao, Q. (2021) · GigaScience · doi:10.1093/gigascience/giab036 · Cited by 26
Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression
Xie, T., Musteanu, M., Lopez-Casas, P. P., Shields, D. J., Olson, P., Rejto, P. A., & Hidalgo, M. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142631 · Cited by 28
Cancer Metastases: So Close and So Far
Sonnenschein, C., & Soto, A. M. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv236 · Cited by 31
Role of α‐gal epitope/anti‐Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer
Tanemura, M., Miyoshi, E., Nagano, H., Eguchi, H., Taniyama, K., Kamiike, W., Mori, M., & Doki, Y. (2012) · Cancer Science · doi:10.1111/cas.12084 · Cited by 27
Multi‐regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer
Li, X., Guo, X., Li, D., Du, X., Yin, C., Chen, C. Y., Wan, F., Bian, Z., Zhang, J., Li, B., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31395 · Cited by 28
A Phenotypic Approach to the Discovery of Potent G-Quadruplex Targeted Drugs
Neidle, S. (2024) · Molecules · doi:10.3390/molecules29153653 · Cited by 26
Tumour and patient factors in renal cell carcinoma—towards personalized therapy
Haddad, A., & Margulis, V. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.71 · Cited by 27
Investigative pathology: leading the post-genomic revolution
Berman, D. M., Bosenberg, M., Orwant, R., Thurberg, B. L., Draetta, G. F., Fletcher, C. D. �., & Loda, M. F. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.147 · Cited by 27
Cancer heterogeneity and “The Struggle for Existence”: Diagnostic and analytical challenges
Horswell, S. D., Matthews, N., & Swanton, C. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.10.031 · Cited by 27
Telomere crisis in kidney epithelial cells promotes the acquisition of a microRNA signature retrieved in aggressive renal cell carcinomas
Castro‐Vega, L. J., Jouravleva, K., Liu-Bordes, W.-Y., Martinez, C., Gestraud, P., Hupé, P., Servant, N., Albaud, B., Gentien, D., Gad, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt029 · Cited by 25
An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients
Reijm, E. A., Sieuwerts, A. M., Smid, M., Vries, J. B., Mostert, B., Onstenk, W., Peeters, D. J. E., Dirix, L. Y., Seynaeve, C., Jager, A., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2155-y · Cited by 27
Constraints in cancer evolution
Venkatesan, S., Birkbak, N. J., & Swanton, C. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160229 · Cited by 28
PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas
Noorani, I., de la Rosa, J., Choi, Y., Strong, A. J., Ponstingl, H., Vijayabaskar, M., Lee, J.-S., Lee, E., Richard-londt, A., Friedrich, M. J., et al. (2020) · Genome Biology · doi:10.1186/s13059-020-02092-2 · Cited by 26
Genetic GIScience: Toward a Place-Based Synthesis of the Genome, Exposome, and Behavome
Jacquez, G. M., Sabel, C. E., & Chen, S. (2015) · Annals of the Association of American Geographers · doi:10.1080/00045608.2015.1018777 · Cited by 26
Enhancement of multimodality texture-based prediction models via optimization of PET and MR image acquisition protocols: a proof of concept
Vallières, M., Laberge, S., Diamant, A., & Naqa, I. E. (2017) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aa8a49 · Cited by 26
Network‐based integration of mRNA and miRNA profiles reveals new target genes involved in pancreatic cancer
Lin, J., Wu, Y., Liang, X., Ji, M., Ying, H., Wang, X., Sun, X., Shao, C., Zhan, L., & Zhang, Y. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22920 · Cited by 26
Genomic Alterations of Dermatofibrosarcoma Protuberans Revealed by Whole Genome Sequencing
Peng, C., Jian, X., Xie, Y., Li, L., Ouyang, J., Tang, L. Y., Zhang, X., Su, J., Zhao, S., Liu, H., et al. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20976 · Cited by 26
Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer
Deharvengt, S. J., Marmarelis, M. E., & Korc, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039684 · Cited by 26
Retracted
Robustness and Backbone Motif of a Cancer Network Regulated by miR-17-92 Cluster during the G1/S Transition
Yang, L., Meng, Y., Bao, C., Liu, W., Ma, C., Li, A., Zhan, X., Shan, G., & Jia, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057009 · Cited by 26
Somatic structural variation and cancer
Tubío, J. M. C. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv016 · Cited by 27
Clonal Evolution in Multiple Myeloma
Fakhri, B., & Vij, R. (2016) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2016.02.025 · Cited by 26
A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma
Matsushita, K., Okuda, T., Mori, S., Konno, M., Eguchi, H., Asai, A., Koseki, J., Iwagami, Y., Yamada, D., Akita, H., et al. (2019) · ChemMedChem · doi:10.1002/cmdc.201900324 · Cited by 27
Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review
Tuo, Z., Zhang, Y., Li, D., Wang, Y., Wu, R., Wang, J., Yu, Q., Ye, L., Shao, F., Wusiman, D., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107302 · Cited by 28
Translational Advances in Oncogene and Tumor-Suppressor Gene Research
Stojchevski, R., Sutanto, E. A., Sutanto, R., Hadzi‐Petrushev, N., Mladenov, M. I., Singh, S. P., Sinha, J. K., Ghosh, S., Yarlagadda, B., Singh, D. K. K., et al. (2025) · Cancers · doi:10.3390/cancers17061008 · Cited by 34
Bladder Tumor Heterogeneity: The Impact on Clinical Treatment
Chen, C., Qi, X. J., Cao, Y. W., Wang, Y. H., Yang, X. C., Shao, S. X., & Niu, H. T. (2015) · Urologia Internationalis · doi:10.1159/000370165 · Cited by 27
Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer
van Roey, R., Brabletz, T., Stemmler, M. P., & Armstark, I. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.753456 · Cited by 26
Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer
Engels, B., Gevaert, T., Everaert, H., Coninck, P. D., Sermeus, A. B. L., Christian, N., Storme, G. A., Verellen, D., & Ridder, M. D. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-34 · Cited by 25
A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis
Costello, E. (2017) · Gut · doi:10.1136/gutjnl-2016-313665 · Cited by 25
Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach
Goto, T., Hirotsu, Y., Amemiya, K., Mochizuki, H., & Omata, M. (2018) · Cancers · doi:10.3390/cancers10070212 · Cited by 25
Origins of chromosome instability unveiled by coupled imaging and genomics
Cosenza, M. R., Gaiatto, A., Erarslan-Uysal, B., Andrades, Á., Sautter, N. L., Simunovic, M., Jendrusch, M., Zumalave, S., Rausch, T., Halavatyi, A. A., et al. (2025) · Nature · doi:10.1038/s41586-025-09632-5 · Cited by 28
Are Metastases from Metastases Clinical Relevant? Computer Modelling of Cancer Spread in a Case of Hepatocellular Carcinoma
Bethge, A., Schumacher, U., Wree, A., & Wedemann, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035689 · Cited by 24
Genomic analyses to select patients for adjuvant chemotherapy: trials and tribulations
Weigelt, B., Reis-Filho, J. S., & Swanton, C. (2012) · Annals of Oncology · doi:10.1093/annonc/mds323 · Cited by 24

Authors: Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., McBride, D. J., Varela, I., Nik-Zainal, S. A., Leroy, C., Jia, M., Menzies, A., Butler, A. P., Teague, J. W., Griffin, C. A., Burton, J., Swerdlow, H., Quail, M. A., Stratton, M. R., Iacobuzio-Donahue, C., & Futreal, P. A.
Affiliations: University of Cambridge (GB)
Johns Hopkins University (US)
Wellcome Sanger Institute (GB)
Institute of Cancer Research (GB)
Corresponding author: Futreal, P. Andrew
ORCID: Campbell, Peter J.
Yachida, Shinichi
Pleasance, Erin D.
Latimer, Calli
McLaren, Stuart
McBride, David J.
Varela, Ignacio
Jia, Mingming
Menzies, Andrew
Teague, Jon W.
Swerdlow, Harold
Quail, Michael A.
Stratton, Michael R.
Futreal, P. Andrew
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2010-10
Volume: 467
Issue: 7319
Pages: 1109-1113
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature09460
PMC: PMC3137369
OpenAlex: W2066254965
Cited by: 1,317
References: 30
Citations by year: 2026: 10 · 2025: 31 · 2024: 33 · 2023: 51 · 2022: 47 · 2021: 86 · 2020: 69 · 2019: 72 · 2018: 75 · 2017: 117 · 2016: 104 · 2015: 119 · 2014: 153 · 2013: 109 · 2012: 135
FWCI: 34.92
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Skip Viragh Foundation
Uehara Memorial Foundation
Wellcome Trust (077012/Z/05/Z, 088340, 093867, WT088340MA)
National Institutes of Health
National Cancer Institute (R01CA140599, K08CA106610, CA140599, CA106610)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: pancreatic cancer, metastasis, genomic instability, chromosomal rearrangements, clonal evolution, telomere dysfunction, G1/S checkpoint, copy number alterations, tumor progression, early detection, therapeutic target, interpatient heterogeneity, tumour dissemination, somatic mutations, GATA4, GATA3
MeSH terms: Adenocarcinoma, Cell Cycle, Clone Cells, DNA Mutational Analysis, Humans, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Organ Specificity, Pancreatic Neoplasms, Mutagenesis, Telomere, Disease Progression, Cell Lineage, Evolution, Molecular, Genomic Instability, Genes, Neoplasm

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks